DelphX Announces Non-Brokered Unit Private Placement
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) has announced an oversubscribed non-brokered private placement offering of 7,090,715 units at C$0.07 per unit, targeting gross proceeds of C$496,350.
Each unit comprises one common share and one purchase warrant, with warrants exercisable at C$0.08 per share for a five-year period. The company will pay cash finder's fees and issue finders' warrants to eligible finders, exercisable at C$0.08 for five years.
The offering requires TSX Venture Exchange approval and includes a four-month plus one-day hold period. Company insiders may participate in the placement, and proceeds will support general corporate purposes.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) ha annunciato un'offerta di collocamento privato non intermediato, sovrascritta, di 7.090.715 unità a C$0,07 per unità, puntando a proventi lordi di C$496.350.
Ogni unità è composta da un'azione comune e da un warrant di acquisto, con warrant esercitabili a C$0,08 per azione per un periodo di cinque anni. L'azienda pagherà commissioni in contante per i mediatori e emetterà warrant per i mediatori idonei, esercitabili a C$0,08 per cinque anni.
L'offerta richiede l'approvazione della Borsa di Toronto Venture e include un periodo di blocco di quattro mesi più un giorno. I membri interni dell'azienda possono partecipare al collocamento e i proventi supporteranno scopi aziendali generali.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) ha anunciado una oferta de colocación privada no intermediada, sobredimensionada, de 7.090.715 unidades a C$0,07 por unidad, con un objetivo de ingresos brutos de C$496.350.
Cada unidad consta de una acción común y un warrant de compra, con warrants ejercitables a C$0,08 por acción durante un período de cinco años. La empresa pagará comisiones en efectivo a los buscadores y emitirá warrants a los buscadores elegibles, ejercitables a C$0,08 durante cinco años.
La oferta requiere la aprobación de la Bolsa de Valores de Toronto Venture e incluye un período de retención de cuatro meses más un día. Los miembros internos de la empresa pueden participar en la colocación y los ingresos apoyarán propósitos corporativos generales.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF)는 7,090,715 유닛을 C$0.07 유닛당에 비중이 초과된 비중개 사모펀드 공모를 발표했습니다. 총 수익 목표는 C$496,350입니다.
각 유닛은 하나의 보통주와 하나의 매수 워런트로 구성되며, 워런트는 5년 동안 C$0.08에 주식으로 행사할 수 있습니다. 회사는 적격 중개인에게 현금 수수료를 지급하고, 5년 동안 C$0.08에 행사 가능한 중개인 워런트를 발행할 것입니다.
이 공모는 TSX 벤처 거래소의 승인이 필요하며, 4개월 + 1일의 보유 기간이 포함됩니다. 회사 내부자는 공모에 참여할 수 있으며, 수익은 일반 기업 목적을 지원하는 데 사용됩니다.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) a annoncé une offre de placement privé non intermédié, sursouscrite, de 7.090.715 unités à C$0,07 par unité, visant des produits bruts de C$496.350.
Chaque unité se compose d'une action ordinaire et d'un bon de souscription, avec des bons exerçables à C$0,08 par action pendant une période de cinq ans. La société paiera des frais de recherche en espèces et émettra des bons aux chercheurs éligibles, exerçables à C$0,08 pendant cinq ans.
L'offre nécessite l'approbation de la Bourse de Toronto Venture et comprend une période de blocage de quatre mois plus un jour. Les membres internes de l'entreprise peuvent participer au placement, et les produits soutiendront des objectifs d'entreprise généraux.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) hat eine überzeichnete nicht vermittelte Privatplatzierung von 7.090.715 Einheiten zu C$0,07 pro Einheit angekündigt, mit dem Ziel, einen Bruttoerlös von C$496.350 zu erzielen.
Jede Einheit besteht aus einer Stammaktie und einem Kaufwarrant, wobei die Warrants für einen Zeitraum von fünf Jahren zu C$0,08 pro Aktie ausgeübt werden können. Das Unternehmen wird Provisionen in bar zahlen und Warrants an berechtigte Vermittler ausgeben, die für fünf Jahre zu C$0,08 ausgeübt werden können.
Die Platzierung bedarf der Genehmigung der TSX Venture Exchange und umfasst eine Sperrfrist von vier Monaten plus einem Tag. Unternehmensinsider können an der Platzierung teilnehmen, und die Erlöse werden allgemeine Unternehmenszwecke unterstützen.
- Offering is oversubscribed, indicating strong investor interest
- Long warrant exercise period of 5 years provides extended funding flexibility
- Insider participation allowed, showing management confidence
- Significant dilution with 7,090,715 new units being issued
- Low unit price of C$0.07 indicates potential company undervaluation
- Additional dilution possible through finder's warrants
Toronto, Ontario--(Newsfile Corp. - March 19, 2025) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products for the fixed income market, announces that it intends to proceed with an oversubscribed non-brokered private placement ("the Offering") of 7,090,715 units (the "Units") at a subscription price of C
In connection with the Offering, DelphX will pay cash finder's fees and issue finders' warrants (the "Finders' Warrants") to eligible finders. The Finders' Warrants will be exercisable at
Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance. DelphX insiders may participate in the Offering, subject to compliance with DelphX's insider trading policy.
DelphX intends to use the net proceeds from the Offering in connection with general corporate purposes.
About DelphX Capital Markets Inc.
DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables fixed income dealers to offer new private placement securities that provide mitigation of spread and capital charge losses when downgrades occur, while allowing for attractive returns. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:
- Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds;
- Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade exposure of an underlying security in exchange for attractive returns.
All CPOs and CRNs are fully collateralized and held in custody by BNY Mellon. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.
For more information about DelphX, please visit www.delphx.com.
George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/245278
FAQ
What are the terms of DelphX Capital Markets (DPXCF) March 2025 private placement?
How much capital is DelphX (DPXCF) raising in its latest private placement?
What is the exercise price and duration of the warrants in DPXCF's 2025 offering?
How long is the hold period for securities issued in DelphX's (DPXCF) private placement?
